Medicine Supply Notification: Flixotide® (fluticasone propionate) 100 microgram Accuhaler – Update

Update: (28/05/2021) Resupply date now w/c 28th June 2021


Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Flixotide® (fluticasone propionate) 100 microgram Accuhaler

MSN/2021/025

Tier 2 – medium impact

Date of issue: 11/05/2021

  • Flixotide® 100 microgram Accuhaler are out of stock until w/c 31st May 2021.
  • Flixotide® 125 microgram Evohaler remain available and able to support a full increase in demand.
  • Flixotide® 50 microgram Evohaler is available and able to support a partial increase in demand.
  • Flixotide® 50 microgram/dose Accuhaler is available and able to support a partial increase in demand.
  • Unlicensed imports of fluticasone 100microgram/dose dry powder inhalers can be sourced. Lead times vary.

Further details, including alternative preparations can be found in the MSN which will have been emailed to community pharmacy teams nhs.net shared mail box directly.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Tell us about your pharmacy's pressures to help us make the case to Government and NHS for more core funding and wider support for the sector.

Click Here